Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIMEGEPANT vs RISDIPLAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RIMEGEPANT vs RISDIPLAM: Safety Overview

Metric RIMEGEPANT RISDIPLAM
Total FAERS Reports 9,175 3,619
Deaths Reported 77 336
Death Rate 0.8% 9.3%
Hospitalizations 217 719
Average Patient Age 50.7 yrs 21.8 yrs
% Female Patients 85.5% 55.2%
FDA Approval Date Feb 27, 2020 Aug 7, 2020
Manufacturer Sportpharm, Inc. dba Sportpharm Genentech, Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription